F2 and blood coagulation disease: COVID-19 ‘s associated coagulation disorder was characterized by increased levels of D-dimer and fibrinogen, and slight abnormalities in prothrombin time, activated partial thromboplastin time and platelet count at the initial stage of infection (9, 10).